Campbell & Co Investment Adviser’s Medtronic MDT Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,748	Closed	-$3.12M	–	1326
2025 Q1	$3.12M	Buy	+34,748	New	+$3.11M	0.24%	91
2022 Q1	–	Sell	-27,750	Closed	-$2.87M	–	813
2021 Q4	$2.87M	Buy	+27,750	New	+$3.21M	0.98%	1
2020 Q3	–	Sell	-2,677	Closed	-$245K	–	441
2020 Q2	$245K	Buy	+2,677	New	+$257K	0.31%	154
2019 Q2	–	Sell	-9,087	Closed	-$828K	–	631
2019 Q1	$828K	Buy	+9,087	New	+$813K	0.41%	39
2017 Q1	–	Sell	-6,580	Closed	-$469K	–	188
2016 Q4	$469K	Buy	+6,580	New	+$517K	1.45%	6
2015 Q3	–	Sell	-4,700	Closed	-$348K	–	365
2015 Q2	$348K	Buy	+4,700	New	+$359K	0.3%	109
2015 Q1	–	Sell	-27,546	Closed	-$1.99M	–	248
2014 Q4	$1.99M	Buy	+27,546	New	+$1.91M	1.22%	16
2014 Q1	–	Sell	-52,004	Closed	-$2.98M	–	260
2013 Q4	$2.98M	Buy	52,004 +13,174	+34%	+$747K	0.67%	55
2013 Q3	$2.07M	Buy	+38,830	New	+$2.09M	0.4%	89

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Campbell & Co Investment Adviser's MDT Position: Q2 2025 in Review

Campbell & Co Investment Adviser sold out of Medtronic (MDT) in Q2 2025, closing a stake of 34,748 shares — an estimated $3.12M sold.

Campbell & Co Investment Adviser first reported a position in MDT in Q3 2013 and held it in 9 quarters. The position peaked at $3.12M in Q1 2025. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

Campbell & Co Investment Adviser reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 34,748 Medtronic shares in Q2 2025, an estimated $3.12M.
Campbell & Co Investment Adviser first reported a position in Medtronic in Q3 2013 and held it in 9 quarters.
Campbell & Co Investment Adviser's Medtronic position peaked at $3.12M in Q1 2025.
2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.